Table 2.
Clinical characteristics of subjects without breast cancer and positivity.
| Patient | Age (Years) | Stage | Pathology | Tumor Size cm | Ab vs. | |||
|---|---|---|---|---|---|---|---|---|
| TPI1 | PRDX2 | PPIA | A1AT | |||||
| 1 | 49 | T0 N0 M0 | N | n/d | − | − | − | + |
| 2 | 43 | T0 N0 M0 | N | n/d | − | − | − | − |
| 3 | 47 | T0 N0 M0 | N | n/d | − | − | − | + |
| 4 | 46 | T0 N0 M0 | N | n/d | − | − | − | − |
| 5 | 50 | T0 N0 M0 | N | n/d | − | + | − | − |
| 6 | 45 | T0 N0 M0 | N | n/d | − | − | − | − |
| 7 | 41 | T0 N0 M0 | N | n/d | − | − | − | − |
| 8 | 47 | T0 N0 M0 | N | n/d | − | − | + | − |
| 9 | 38 | T0 N0 M0 | N | n/d | − | − | − | − |
| 10 | 48 | T0 N0 M0 | N | n/d | − | − | − | − |
| 11 | 46 | T0 N0 M0 | N | n/d | − | − | − | − |
| 12 | 50 | T0 N0 M0 | N | n/d | − | − | − | − |
Ab, antibody; ID, infiltrating Ductal; IL, Infiltrating Lobular; +, positive for protein, −, negative for protein. n/d, not detected.